A phase I/II pilot study of the safety of the adoptive transfer of syngeneic gene-modified cytotoxic T lymphocytes in HIV-infected identical twins

Human Gene Therapy

Volumn 7, Issue 3, 1996, Pages 367-400

  Walker, R E ^a   Blaese, R M ^a   Davey, R T ^a   Falloon, J ^a   Mullen, C ^a   Polis, M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; ANTIPYRETIC AGENT; ANTIVIRUS AGENT; DIPHENHYDRAMINE; PARACETAMOL; PETHIDINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CULTURE; CHILL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKAPHERESIS; MEDICAL ETHICS; METHODOLOGY; MYALGIA; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RAT; SAFETY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030038944     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.3-367     Document Type: Article

References (38)

1. Estimates of HIV prevalence and projected AIDS cases: Summary of a workshop, October 31-November 1, 1989. MMWR 39:110-119 (1990).
2. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500 (1984).
3. Barre-Sinoussi F, Nugeyre M, Dauguet C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 220:868 (1983).
4. Popovic M, Sarngadharon MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497 (1984).
5. Curran JW, Jaffe HW, Hardy AM. Epidemiology of HIV infection and AIDS in the United States. Science 239:610 (1988).
6. Mann J, Chin J, Piot P, Quinn T. The International Epidemiology of AIDS. Scientific American 259:82-89 (1988).
7. Fauci AS. Combination therapy for HIV infection: getting closer. Ann Intern Med 116:85-86 (1992).
8. Fisch MA, Richman DD, Causey DM, et al. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS related complex. AZT Collaborative Working Group. JAMA 262:2405-2410 (1989).
9. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321:1621-1625 (1989).
10. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 317:192-197 (1987).
11. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734 (1989).
12. Kenny AB, Hitzig WH. Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977. Eur J Pediatr 131:155-177 (1979).
13. Vossen JM. Bone marrow transplantation in the treatment of primary immunodeficiencies. Ann Clin Res 19:285-292 (1987).
14. Bortin MM, Rimm AA. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA 238:591-600 (1977).
15. Lane HC, Kovacs JA, Feinberg J. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet 2:1218-1222 (1988).
16. Rook AH, Masur H, Lane HC, et al. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 72:398-403 (1987).
17. Lane HC, Masur H, Longo D, et al. Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome. N Engl J Med 311:1099-1103 (1984).
18. Mitsuyasu R, Volberding P, Groopman J, et al. Bone marrow transplantation from identical twins in the treatment of AIDS and Kaposi's sarcoma [Abstract]. J Cell Biochem 8A:22 (1987).
19. Hassett JM, Zaroulis CG, Greenberg ML, et al. Bone marrow transplantation in AIDS [Letter]. N Engl J Med 309:665 (1983).
20. Davis KC, Hayward A, Ozturk G, et al. Lymphocyte transfusion in case of acquired immunodeficiency syndrome [Letter]. Lancet 1:599-600 (1983).
21. Vilmer E, Rhoces-Feuillette A, Rabian C, et al. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 44:25-29 (1987).
22. Verdonck LF, ce Gast GC, Lange JM, et al. Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation. Blood 71:666-671 (1988).
23. + T Lymphocytes in Patients With AIDS-Related Complex or AIDS. Blood 81:2093-2101 (1993).
24. Lane HC, Zunich KM, Wilson W, et al. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med 113:512-519 (1990).
25. Anderson WF. Prospects for human gene therapy. Science 226:401-409 (1984).
26. Friedman T. Progress toward human gene therapy. Science 244:1275-1280 (1989).
27. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319:1676-1680 (1988).
28. Aebersold P, Kasid A, Rosenberg SA. Selection of gene marked tumor infiltrating lymphocytes from post-treatment biopsies: A case study. Human Gene Ther 1:373-384 (1990).
29. Rosernberg SA, Aebersold P, Cornetta K, et al. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl J Med 323:570-588 (1990).
30. Anderson WF. Steady Progress [Editorial]. Human Gene Ther 2:99-100 (1991).
31. Jolly DJ. HIV infection and gene transfer therapy. Human Gene Ther 2:111-112 (1991).
32. Barber JD, Jolly DJ, St. Louis D, et al. Utilization of retroviral vectors for the potential treatment of AIDS. Annual Review of AIDS Research (in press).
33. + T cell clones vary in function in vitro and in influenza infection in vivo. International Immunol. 2:323-328 (1990).
34. Cannon MJ, Openshaw PJM, Askonas BA. Cytotoxic T Cells Clear Virus but Augment Lung Pathology in Mice Infected with Respiratory Syncytial Virus. J Exp Med 163:1163-1168 (1988).
35. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T-cell lymphoma in non-human primates following retroviral mediated gene transfer. J Exp Med 176:1125-1135, 1992.
36. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to HIV-1 in seronegative homosexual men with recent exposure to HIV-1. J Infect Dis 165:1012-1019 (1992).
37. Joly P, Guillon JM, Plata F, et al. Cell-mediated suppression of HIV-specific cytotoxic lymphocytes. J Immunol 143:2193-2201 (1989).
38. + lymphocytes can control HIV infection in vitro by suppressing viral replication. Science 234:1563-1566 (1986).